Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes
Marco Witkowski(Cleveland Clinic), Ursula Rauch(Charité - Universitätsmedizin Berlin), Diethelm Tschoepe(Heart and Diabetes Center North Rhine-Westphalia), Sinah Grabitz(Charité - Universitätsmedizin Berlin), Lena Taghipour(Charité - Universitätsmedizin Berlin), Bernd Stratmann(Heart and Diabetes Center North Rhine-Westphalia), Julian Friebel(Humboldt-Universität zu Berlin), Kai Jakobs(Charité - Universitätsmedizin Berlin), Ulf Landmesser(University of Zurich), Termeh Tabaraie(Johannes Gutenberg University Mainz), Andrea Dörner(Charité - Universitätsmedizin Berlin)
Cited by 23
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k